2014
DOI: 10.1111/iwj.12315
|View full text |Cite
|
Sign up to set email alerts
|

Cdc42 and p190RhoGAP activation by CCN2 regulates cell spreading and polarity and induces actin disassembly in migrating keratinocytes

Abstract: Cell migration requires spatiotemporal integration of signals that regulate cytoskeletal dynamics. In response to a migration-promoting agent, cells begin to polarise and extend protrusions in the direction of migration. These cytoskeletal rearrangements are orchestrated by a variety of proteins, including focal adhesion kinase (FAK) and the Rho family of GTPases. CCN2, also known as connective tissue growth factor, has emerged as a regulator of cell migration but the mechanism by which CCN2 regulates keratino… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(11 citation statements)
references
References 72 publications
(78 reference statements)
0
11
0
Order By: Relevance
“…Cdc42 has been proposed to be a key signaling molecule that drives cell polarization and cell migration (Nobes and Hall, 1999; Etienne-Manneville and Hall, 2001), although with some disagreement between experiments using dominant-negative, knockout, and small molecule inhibitors in different cell types and culture conditions (Nobes and Hall, 1999; Etienne-Manneville and Hall, 2001; Cau and Hall, 2005; Czuchra et al , 2005; Kiwanuka et al , 2016). We tested the requirement for Cdc42 for GOLPH3-driven cell migration using the specific Cdc42 inhibitor, ML141 (Hong et al , 2013; Kiwanuka et al , 2016).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Cdc42 has been proposed to be a key signaling molecule that drives cell polarization and cell migration (Nobes and Hall, 1999; Etienne-Manneville and Hall, 2001), although with some disagreement between experiments using dominant-negative, knockout, and small molecule inhibitors in different cell types and culture conditions (Nobes and Hall, 1999; Etienne-Manneville and Hall, 2001; Cau and Hall, 2005; Czuchra et al , 2005; Kiwanuka et al , 2016). We tested the requirement for Cdc42 for GOLPH3-driven cell migration using the specific Cdc42 inhibitor, ML141 (Hong et al , 2013; Kiwanuka et al , 2016).…”
Section: Resultsmentioning
confidence: 99%
“…We tested the requirement for Cdc42 for GOLPH3-driven cell migration using the specific Cdc42 inhibitor, ML141 (Hong et al , 2013; Kiwanuka et al , 2016). We performed scratch wound healing assays in control (DMSO) or ML141-treated cells (Figure 3E and Supplemental Figure 2D).…”
Section: Resultsmentioning
confidence: 99%
“…However, changes in endothelial cytoskeleton, adherens junctions, and permeability do correlate with Cdc42 activity in a model of hypoxia-induced neonatal pulmonary hypertension (Wojciak-Stothard et al, 2006 ). Importantly, CTGF works in concert with other protein mediators to increase the angiogenic response to injury, including downstream Cdc42 activation (Pi et al, 2012 ; Kiwanuka et al, 2016 ). Thus, it is interesting to speculate—based on our findings—that the spatiotemporal integration of signals that regulate cytoskeletal dynamics through CTGF, specifically Cdc42, are necessary for PH development.…”
Section: Discussionmentioning
confidence: 99%
“…The preparation of GST fusion proteins and the pull down assay for active Rac1, Cdc42 and RhoA was performed according to a previously reported procedure. 23 Briefly, PMVECs were grown in six wells culture-plates for 2 days and stimulated with 5% normal or CBDL rat serum (4 weeks). For treatment groups, PMVECs were added with 0.05 μM PTEN inhibitor BpV(pic) (Abcam) or 5 μM Casin (Sigma-Aldrich) for 24 hours in different groups.…”
Section: Rho Gtpase Pull Down Assaysmentioning
confidence: 99%